ArticleBrain pathology (Zurich, Switzerland)2008

Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.

Matthias Preusser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.